SHORT MINI-FUTURE - BRISTOL-MYERS SQUIBB | Market Closed - Deutsche Boerse AG 18:40:20 20/06/2024 BST | ||
| 3.89 EUR | +1.04% |
|
| Current month | +1.83% | ||
| 1 month | +9.58% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BRISTOL-MYERS SQUIBB COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 20/06/24 | 3.89 | +1.04% |
| 19/06/24 | 3.85 | -1.28% |
| 18/06/24 | 3.9 | +1.04% |
| 17/06/24 | 3.86 | +1.05% |
| 14/06/24 | 3.82 | +0.26% |
Delayed Quote Deutsche Boerse AG
Last update June 20, 2024 at 06:40 pm
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | BRISTOL-MYERS SQUIBB COMPANY |
| Issuer | 
Vontobel
|
| WKN | VU0QS9 |
| ISIN | DE000VU0QS90 |
| Date issued | 12/12/2022 |
| Strike | 82.41 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 0.52 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 3.9 € |
|---|---|
| Lowest since issue | 0.46 € |
Company Profile
Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques.
The United States account for 70.1% of net sales.
Sector
-
Ratings for Bristol-Myers Squibb Company
Trading Rating
Investor Rating
ESG Refinitiv
B
Consensus: Bristol-Myers Squibb Company
Sell
Buy
Mean consensus
HOLD
Number of Analysts
26
Last Close Price
41.04
USD
Average target price
53.19
USD
Spread / Average Target
+29.62%
- Stock Market
- Certificates
- Certificat
